Swirski obtained his PhD in immunology from McMaster University in Canada and completed his postdoctoral studies in vascular biology at Brigham and Women's Hospital and Massachusetts General Hospital. His lab focuses on leukocytedynamics in cardiovascular disease. He is currently working on how extramedullary myelopoiesis influences the evolution of atherosclerotic lesions.